OpenAlex
PricingAboutJobs
Log inGet started
Work

Prioritization of EGFR/IGF-IR/VEGFR2 combination targeted therapies utilizing cancer models.

PubMed

Year: 2009
Type: article
Source: PubMed
Authors: James R Tonra, Erik Corcoran, Dhanvanthri S Deevi, Philipp Steiner, Jessica Kearney, Huiling Li, Dale L Ludwig, Zhenping Zhu, Larry Witte, David Surguladze, Daniel J Hicklin
Institution: Eli Lilly (United States)
Language: English

Topic: Angiogenesis and VEGF in Cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: EGFR, IGF-1 receptor, VEGFR2, combination targeted therapy, cetuximab, DC101, tumor xenograft models, drug resistance, colorectal cancer, pancreatic cancer, tumor hypoxia, vascular endothelial growth factor, blood vessel density, metastasis
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W129605
FWCI: 0.858
Cites: 28
Cited by: 14
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms